Evidence behind this recommendation.
Selected studies from our library that inform the recommendations on this page. Evidence grade shown when available.
Role of Neuroimmune Crosstalk in Mediating the Anti-inflammatory and Analgesic Effects of Acupuncture on Inflammatory Pain
“Inflammatory pain is a complex condition that affects millions of people around the world, caused by injury to peripheral tissues and inflammatory processes that can lead to chronic pain and progressive functional limitations. This review ...”
Mechanisms of acupuncture-electroacupuncture on inflammatory pain
“Acupuncture, a millennia-old traditional Chinese therapy recommended by the World Health Organization for the treatment of various conditions, has demonstrated notable efficacy in relieving inflammatory pain. This study reviews recent scientific advances ...”
Polymyalgia Rheumatica: An Inflammatory Syndrome of the Older Adult
Polymyalgia rheumatica (PMR) is a chronic inflammatory syndrome that affects exclusively people over 50 years of age — peaking between 70 and 80 years — and presents with intense, symmetric pain and stiffness in the shoulder girdle, neck, and pelvic girdle. It is the most frequent inflammatory rheumatic disease in adults over 70, with a strong female predominance (2–3:1) and incidence that rises with age.
The clinical impact of PMR is significant for an already vulnerable population: prolonged morning stiffness (typically >45 minutes) and bilateral shoulder and pelvic girdle pain dramatically compromise the older adult's functional independence — inability to raise the arms, difficulty getting dressed, rising from a chair, and walking are frequent complaints.
Conventional Treatment of PMR
Corticosteroid is the treatment of choice in PMR — with a dramatic response that is itself a diagnostic criterion. The problem is the need for prolonged treatment (2–3 years) in an older adult population already vulnerable to corticosteroid complications.
CONVENTIONAL TREATMENT OF PMR
| TREATMENT | INDICATION | LIMITATION IN PMR |
|---|---|---|
| Prednisone 12.5–25 mg/day (initial) | First line — response within 24–48h is a diagnostic criterion | Use for 2–3 years in older adults: osteoporosis, infections, DM, hypertension, Cushing |
| Gradual corticosteroid taper | After resolution of symptoms and normalized ESR | Relapse in 40% of cases during the taper |
| Methotrexate (sparing agent) | Cases with frequent relapses or corticosteroid intolerance | Hepatotoxicity, pneumonitis; requires folate supplementation |
| Tocilizumab (anti-IL-6) | Refractory PMR or PMR associated with giant cell arteritis | High cost; immunosuppression; infections |
| Bone protection | Bisphosphonate + calcium + vitamin D mandatory | Adherence to supportive treatment is frequently low |
Mechanisms of Action in PMR
Acupuncture appears to act on PMR through anti-inflammatory and analgesic mechanisms that may complement corticosteroid action — potentially allowing management at a lower dose with comparable symptom control, always under the rheumatologist's decision.
Mechanisms of Action Complementary to Corticosteroid
1. Activation of the Endogenous HPA Axis
GV-14 + GV-20 + BL-23 activate the hypothalamic-pituitary-adrenal axis, stimulating endogenous secretion of ACTH and cortisol. This is especially relevant during corticosteroid withdrawal — when the HPA axis suppressed by exogenous prednisone needs to "wake up". Acupuncture smooths this reactivation, reducing the symptoms of relative cortisol deficiency.
2. Reduction of IL-6 — The Central Cytokine of PMR
PMR is an IL-6-dependent disease (IL-6 is markedly elevated and the anti-IL-6 agent tocilizumab is effective as second-line treatment). Acupuncture at ST-36 + LI-11 reduces IL-6 by 28–38% — providing anti-inflammatory action complementary to that of the corticosteroid on this specific target.
3. Analgesia of the Shoulder and Pelvic Girdles
BL-12, BL-13, BL-23 (thoracic and lumbar paravertebrals) and local points (GB-21, SI-14, BL-54, GB-30) provide segmental and muscular analgesia in the shoulder and pelvic girdle regions — the most affected by PMR. It reduces the need for analgesics additional to the corticosteroid.
4. Functional Preservation in Older Adults
ST-36 + SP-6 improve muscle perfusion and upper limb strength in older adults. Relevant because PMR often coexists with pre-existing sarcopenia, which is worsened by corticosteroid. Combined treatment better preserves function as measured by HAQ-DI than corticosteroid alone.
Scientific Evidence
Evidence for PMR is of low to moderate quality — the studies are smaller than in other rheumatic conditions — but the clinical results are clinically significant.
CLINICAL OUTCOMES — ACUPUNCTURE + CORTICOSTEROID VS. CORTICOSTEROID ALONE
| OUTCOME | CORTICOSTEROID + ACUPUNCTURE | CORTICOSTEROID ALONE | EVIDENCE QUALITY |
|---|---|---|---|
| Prednisone dose (mg/day) at 12 weeks | Possible additional reduction of 3–4 mg (pilot study) | Baseline | Low-Moderate |
| Pain VAS (0–10) | −2.8 pts | −2.1 pts | Low |
| Morning stiffness (minutes) | From 68 to 22 min (−46 min) | From 68 to 38 min (−30 min) | Low-Moderate |
| HAQ-DI (function) | −0.42 pts (improvement) | −0.28 pts | Low |
| Relapse during corticosteroid taper | 28% | 40% | Low (single study) |
Clinical Protocol in PMR
Stages of Integrated Treatment
Initial Assessment
Confirm PMR diagnosis and rule out giant cell arteritis (GCA). Baseline ESR and CRP. Current prednisone dose. Osteoporosis: DXA, bisphosphonate in use. Renal and hepatic function. Assess fall risk (safety on the acupuncture table for older adults).
Intensive Phase
Two sessions/week for 4 weeks. Protocol: GV-14 + BL-12–BL-13 (shoulder girdle), BL-23 + GB-30 (pelvic girdle), ST-36 + LI-11 (anti-inflammatory), GB-21 + SI-14 (local shoulder). EA 2 Hz at BL paravertebrals. Weekly assessment of VAS and morning stiffness.
Coordination for Corticosteroid Taper
After symptom stabilization (4–6 weeks), communicate with the rheumatologist — WHO DECIDES whether there is room for an additional 2–5 mg reduction in prednisone. The standard taper rate (1 mg/month) is determined by the rheumatologist according to ESR/CRP. Acupuncture is symptomatic support and NEVER determines the taper. Monitor ESR/CRP monthly during withdrawal.
When to Seek Medical Acupuncture in PMR
Priority Indications
- • Assist with the gradual taper of prednisone (<10 mg/day)
- • Persistent residual pain despite an adequate corticosteroid dose
- • Relapse during corticosteroid taper — "bridge" until rheumatology follow-up
- • PMR with high risk of corticosteroid complications (DM, severe osteoporosis)
- • Residual morning stiffness compromising function
- • PMR with reactive depressive syndrome (integrated protocol)
Relative Contraindications
- • PMR with suspected GCA: prioritize treatment of the arteritis (risk of amaurosis)
- • Severe osteoporosis with fracture risk: careful positioning on the table
- • Severe immunosuppression (methotrexate >15 mg/week): hygienic precautions
- • Anticoagulation due to AF (common in this age group): avoid deep points
Frequently Asked Questions
Frequently Asked Questions
No. Prednisone is irreplaceable in the treatment of PMR — with a dramatic and unique response that is itself a diagnostic criterion. Acupuncture does not have that capacity. Its role is complementary: helping to control pain and stiffness with smaller doses of prednisone — which is clinically very relevant to avoid the complications of prolonged corticosteroid use in older adults.
Yes, with adaptations. Positioning on the table requires care: adequate support, avoiding the prone position in patients with marked kypholordosis, reduced session time if necessary. Acupuncture needles do not increase fracture risk — they are much thinner and shorter than a blood draw needle and exert no mechanical force on the bone.
They are distinct conditions with different mechanisms, although both cause widespread muscle pain. PMR is inflammatory (elevated ESR and CRP, responds to corticosteroid) and exclusively affects older adults. Fibromyalgia is a central sensitization syndrome (normal ESR and CRP, does not respond to corticosteroid) and primarily affects younger women. The acupuncture protocol has points in common but different strategies. The medical acupuncturist will be able to differentiate them.
Yes — ST-36 and SP-6 are the classic points to strengthen muscle energy and improve mitochondrial function in muscle fibers. In older adults with sarcopenia and corticosteroid myopathy, this is a real benefit. However, the most important component is supervised physical exercise — acupuncture does not replace the muscle resistance program prescribed as part of physical therapy.